Form 8-K - Current report:
SEC Accession No. 0001628280-20-012429
Filing Date
2020-08-11
Accepted
2020-08-11 16:04:21
Documents
4
Period of Report
2020-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crdf8-k081120.htm 8-K 37113
2 EX-99.1 crdf81120-q22020pr.htm EX-99.1 190295
3 cardifflogorgbtm11.jpg GRAPHIC 176318
4 cardifflogorgbtm2.jpg GRAPHIC 176318
  Complete submission text file 0001628280-20-012429.txt   685407
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 201092415
SIC: 2836 Biological Products, (No Diagnostic Substances)